Prostate Health Market
Prostate Health Market Size, Share & Trends Analysis Report
Prostate Health Market Size, Share, Statistics & Trends Analysis Report By Disease Indication (Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis), By Treatment Type (Prostate Cancer: AR Directed Therapies, Hormone ADT, Cytotoxic Agents, PARP Inhibitors, Others; Benign Prostate Hyperplasia: Alpha Blockers: Alfuzosin, Doxazosin, Tamsulosin, Silodosin, Other Alpha Blockers, 5 Alpha Reductase: Finasteride, Dutasteride, Others; Prostatitis: Prescription, Over the Counter) Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 3006
Number of pages : 300
Published Date : Jul 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Segmentation
By Disease Indication
- Prostate Cancer
- AR Directed Therapies
- Hormone ADT
- Cytotoxic Agents
- PARP Inhibitors
- Others
- Benign Prostate Hyperplasia
- Alpha Blockers
- Alfuzosin
- Doxazosin
- Tamsulosin
- Silodosin
- Other Alpha Blockers
- 5 Alpha Reductase
- Finasteride
- Dutasteride
- Others
- Prostatitis
- Prescription
- Over the counter
Key Players
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Dendreon Pharmaceuticals LLC
- Endo Pharmaceuticals, Inc.
- Ipsen Pharma
- Johnson & Johnson Services
- Pfizer, Inc.
- Sanofi
SUMMARY
Segments
By Disease Indication
- Prostate Cancer
- AR Directed Therapies
- Hormone ADT
- Cytotoxic Agents
- PARP Inhibitors
- Others
- Benign Prostate Hyperplasia
- Alpha Blockers
- Alfuzosin
- Doxazosin
- Tamsulosin
- Silodosin
- Other Alpha Blockers
- 5 Alpha Reductase
- Finasteride
- Dutasteride
- Others
- Prostatitis
- Prescription
- Over the counter
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Dendreon Pharmaceuticals LLC
- Endo Pharmaceuticals, Inc.
- Ipsen Pharma
- Johnson & Johnson Services
- Pfizer, Inc.
- Sanofi
